Asna Amin

468 total citations
11 papers, 380 citations indexed

About

Asna Amin is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Asna Amin has authored 11 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Immunology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Asna Amin's work include Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and vaccines and immunoinformatics approaches (3 papers). Asna Amin is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and vaccines and immunoinformatics approaches (3 papers). Asna Amin collaborates with scholars based in United States. Asna Amin's co-authors include George E. Peoples, Sathibalan Ponniah, Jarrod P. Holmes, Matthew T. Hueman, Elizabeth A. Mittendorf, Dianna Craig, Mark G. Carmichael, Jeremy D. Gates, Catherine E. Storrer and Linda C. Benavides and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Asna Amin

10 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asna Amin United States 8 277 241 156 145 22 11 380
Dianna Craig United States 5 337 1.2× 296 1.2× 202 1.3× 169 1.2× 20 0.9× 9 427
Reynold Yee United States 10 196 0.7× 226 0.9× 48 0.3× 167 1.2× 16 0.7× 11 314
Abraham Sachs United States 4 244 0.9× 285 1.2× 80 0.5× 145 1.0× 14 0.6× 4 381
Ann Murphy United States 3 422 1.5× 257 1.1× 249 1.6× 245 1.7× 21 1.0× 6 553
Christine Stemmer France 8 226 0.8× 108 0.4× 44 0.3× 102 0.7× 21 1.0× 10 352
Shelly Kalaora Israel 7 251 0.9× 229 1.0× 43 0.3× 265 1.8× 40 1.8× 8 447
Mohamed Benhammadi Canada 4 246 0.9× 164 0.7× 56 0.4× 247 1.7× 9 0.4× 5 390
Sofie Ramskov Denmark 6 260 0.9× 181 0.8× 55 0.4× 132 0.9× 18 0.8× 8 341
Jenifer Widger United States 6 235 0.8× 136 0.6× 47 0.3× 93 0.6× 16 0.7× 11 309
Ufuk Karakus Switzerland 7 223 0.8× 163 0.7× 45 0.3× 141 1.0× 11 0.5× 12 397

Countries citing papers authored by Asna Amin

Since Specialization
Citations

This map shows the geographic impact of Asna Amin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asna Amin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asna Amin more than expected).

Fields of papers citing papers by Asna Amin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asna Amin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asna Amin. The network helps show where Asna Amin may publish in the future.

Co-authorship network of co-authors of Asna Amin

This figure shows the co-authorship network connecting the top 25 collaborators of Asna Amin. A scholar is included among the top collaborators of Asna Amin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asna Amin. Asna Amin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Amin, Asna, et al.. (2014). Fatal Ischemic Proctitis in a Patient with a History of an Aortobi-iliac Interposition Graft. The American Surgeon. 80(8). 234–235.
2.
Clifton, Guy T., Jarrod P. Holmes, Asna Amin, et al.. (2009). Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/ neu -Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial. Journal of the American College of Surgeons. 210(2). 140–147. 38 indexed citations
4.
Holmes, Jarrod P., Linda C. Benavides, Jeremy D. Gates, et al.. (2008). Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/neuPeptide (AE37) Vaccine. Journal of Clinical Oncology. 26(20). 3426–3433. 112 indexed citations
5.
Peoples, George E., Jarrod P. Holmes, Matthew T. Hueman, et al.. (2008). Combined Clinical Trial Results of a HER2/neu(E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02. Clinical Cancer Research. 14(3). 797–803. 140 indexed citations
6.
Amin, Asna, et al.. (2008). Patients Requiring Dialysis are not at Risk of Greater Complication after Carotid Endarterectomy. Vascular. 16(3). 167–170. 12 indexed citations
7.
Amin, Asna, Craig D. Shriver, Leonard R. Henry, et al.. (2007). Breast cancer screening compliance among young women in a free access healthcare system. Journal of Surgical Oncology. 97(1). 20–24. 14 indexed citations
8.
Stojadinovic, Alexander, Elizabeth A. Mittendorf, Jarrod P. Holmes, et al.. (2007). Quantification and Phenotypic Characterization of Circulating Tumor Cells for Monitoring Response to a Preventive HER2/neu Vaccine-Based Immunotherapy for Breast Cancer: A Pilot Study. Annals of Surgical Oncology. 14(12). 3359–3368. 23 indexed citations
9.
Holmes, Jarrod P., Asna Amin, Catherine E. Storrer, et al.. (2007). Clinical and immunologic effects of a HER2/neu (E75) peptide vaccine booster in previously vaccinated breast cancer patients. Journal of Clinical Oncology. 25(18_suppl). 3014–3014. 3 indexed citations
10.
Amin, Asna, Alexander Stojadinovic, Jarrod P. Holmes, et al.. (2007). Assessment of circulating tumor cell (CTC) patterns among disease-free breast cancer patients vaccinated with a preventive HER2/neu E75-peptide vaccine. Journal of Clinical Oncology. 25(18_suppl). 3059–3059. 1 indexed citations
11.
Hoke, David E., E. Gloria C. Regisford, JoAnne Julian, et al.. (1998). Murine HIP/L29 Is a Heparin-binding Protein with a Restricted Pattern of Expression in Adult Tissues. Journal of Biological Chemistry. 273(39). 25148–25157. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026